SpaceX (SPCX) Stock Gains Momentum Following JPMorgan’s $240 Price Target Reaffirmation
4 Articles
4 Articles
Why SpaceX stock is surging over 2% today
SpaceX (SPCX) shares rose about 2.5% on Tuesday after closing at its initial public offering price Monday, as JPMorgan highlighted the company's expanding artificial intelligence ambitions and enterprise strategy. JPMorgan reiterated an Overweight rating and $240 price target on SpaceX, implying roughly 74% upside from the stock's current price. JPMorgan sees AI opportunity JPMorgan's bullish view centers partly on SpaceX's acquisition of Cursor…
SpaceX (SPCX) Stock Gains Momentum Following JPMorgan’s $240 Price Target Reaffirmation
SpaceX (SPCX) stock climbed 1.6% Tuesday as JPMorgan maintained its $240 target, highlighting Grok AI progress and the strategic Cursor acquisition. The post SpaceX (SPCX) Stock Gains Momentum Following JPMorgan’s $240 Price Target Reaffirmation appeared first on Blockonomi.
SpaceX (SPCX) Stock Gains Momentum Following JPMorgan's $240 Price Target Reaffirmation
Key Highlights Shares of SpaceX gained 1.6% in Tuesday’s early session, reaching $137.10 after closing at $135 following its June IPO JPMorgan maintained its Overweight rating with a $240 price objective, suggesting potential upside of approximately 78% Doug Anmuth from JPMorgan highlighted Grok 4.6’s impressive advancement, with Grok 5 anticipated by December The completed Cursor deal, finalized August 14, contributes approximately $4 billion …
SpaceX Stock Price: JPMorgan Keeps $240 Target
The post SpaceX Stock Price: JPMorgan Keeps $240 Target appeared first on Coinpedia Fintech News JPMorgan reiterated its Overweight rating and $240 price target for SpaceX, citing growing confidence in Grok’s AI prospects. The firm highlighted SpaceX’s reported acquisition of Cursor, which generates about $4 billion in annual recurring revenue, with 75% from businesses. JPMorgan expects Cursor to support SpaceX’s enterprise AI strategy, model tr…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium





